Nafasolina
NDC Package 48462-001-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nafasolina is adults and children 12 years of age and over: 1 or 2 drops in each nostril not more often than every 6 hours. Marketed by Duy Drugs, Inc, this product is identified by NDC 48462-001 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
48462-001-02
Package Description
13310 BOTTLE, DROPPER in 1 CARTON / 13310 mg in 1 BOTTLE, DROPPER (48462-001-01)
Product Code
11-Digit Billing Format
48462000102

Clinical Specifications

Proprietary Name
Nafasolina
Dosage Form
-
Usage Information
Adults and children 12 years of age and over: 1 or 2 drops in each nostril not more often than every 6 hours. Do not give to children under 12 years of age unless directed by a doctor.

Regulatory & Marketing

Labeler Name
Duy Drugs, Inc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-15-2021
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 48462-001-02 identifies a specific commercial package of 13310 bottle, dropper in 1 carton / 13310 mg in 1 bottle, dropper (48462-001-01) of Nafasolina, labeled by Duy Drugs, Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Duy Drugs, Inc on February 15, 2021. The current certification is valid through December 31, 2022.

How is this Duy Drugs, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 48462000102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
48462-001-02
11-Digit CMS (5-4-2)
48462-0001-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.